Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 20
Number of items: 20
  • Open Access
    Kummer, L. Y. L., Kuijper, L. H., Fernández Blanco, L., Bos, A., Kreher, C., Verstegen, N. J. M., Duurland, M. C., Konijn, V. A. L., Jorritsma, T., Tempert, M., Menage, C., Steenhuis, M., van Gils, M. J., Claireaux, M., Garcia-Vallejo, J. J., D’Haens, G. R. A. M., Löwenberg, M., Volkers, A. G., van Dam, K. P. J., ... ten Brinke, A. (2025). TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination. RMD OPEN, 11(3), Article e005724. https://doi.org/10.1136/rmdopen-2025-005724
  • Open Access
    Kummer, L. Y. L., Fernández Blanco, L., Kreher, C., Bos, A., Kuijper, L. H., Verstegen, N. J. M., van de Sandt, C. E., Konijn, V. A. L., Duurland, M. C., Menage, C., Jorritsma, T., Steenhuis, M., Hagen, R. R., van den Dijssel, J., de Jongh, R., Ashhurst, T., van Gils, M. J., Garcia-Vallejo, J. J., Claireaux, M., ... T2B! immunity against SARS-CoV-2 study group (2024). Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID. RMD OPEN, 10(4), Article e004664. https://doi.org/10.1136/rmdopen-2024-004664
  • Open Access
    Verstegen, N. J. M., Hagen, R. R., Kreher, C., Kuijper, L. H., Dijssel, J. V. D., Ashhurst, T., Kummer, L. Y. L., Palomares Cabeza, V., Steenhuis, M., Duurland, M. C., Jongh, R. D., Schoot, C. E. V. D., Konijn, V. A. L., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G., ... T2B! immunity against SARS-CoV-2 study group (2024). T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination. Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 855–864. https://doi.org/10.1136/jnnp-2023-332224
  • Open Access
    Verstegen, N. J. M., Jorritsma, T., ten Brinke, A., Barberis, M., & van Ham, S. M. (2024). TCR-CD3 signal strength regulates plastic coexpression of IL-4 and IFN-γ in Tfh-like cells. Frontiers in Immunology, 15, Article 1481243. https://doi.org/10.3389/fimmu.2024.1481243
  • van Dam, K. P. J., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Busch, M. H., Verstegen, N. J. M., van Ham, S. M., Tas, S. W., & T2B! immunity against SARS-CoV-2 study group (2023). Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations. Journal of autoimmunity, 135, Article 102984. https://doi.org/10.1016/j.jaut.2022.102984
  • Open Access
    van Dam, K. P. J., Tas, S. W., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Busch, M. H., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2023). Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity. BMC Infectious Diseases, 23, Article 332. https://doi.org/10.1186/s12879-023-08298-6
  • Open Access
    Verstegen, N. J. M. C. (2023). Going beyond your form: T-cell dependent B-cell fate determination. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Verstegen, N. J. M., Pollastro, S., Unger, P.-PA., Marsman, C., Elias, G., Jorritsma, T., Streutker, M., Bassler, K., Haendler, K., Rispens, T., Schultze, J. L., ten Brinke, A., Beyer, M., & van Ham, S. M. (2023). Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates. eLife, 12, Article e83578. https://doi.org/10.7554/elife.83578
  • Stalman, E. W., Tas, S. W., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases. Annals of the Rheumatic Diseases, 81(12), 1757-1766. https://doi.org/10.1136/ard-2022-222904
  • Boekel, L., Tas, S. W., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies. The Lancet. Rheumatology, 4(6), e417-e429. https://doi.org/10.1016/S2665-9913(22)00102-3
Page 1 of 2